Tina Susan Nova Receives Stock Award at Exagen Inc (XGN) — SEC Form 4, Nov 02, 2026

SEC Form 4 · No Market Transaction
Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner
Director
TXN 2026-06-09 · FILED 2026-11-02
Filing Lag 100 business days late vs 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-11-02
Report Date
2026-11-02
Accession No.
0001274737-26-000058
Accepted At
2026-11-02 23:55 UTC
Reporting Owner
Name Relationship
Tina Susan Nova CIK 0001302605
Director
Tina Susan Nova at Exagen Inc Full insider history
Bought (12 mo) —
Sold (12 mo) —
More from this insider at Exagen Inc
All filings by this insider at Exagen Inc
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Stock Option(right to buy)F1 $4.31 2026-06-09 A - Award/Grant 56,200 A $0.00 2036-06-08 56,200 Common Stock Direct
Footnotes (1)
F1
The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Show more
5%+ Holders · 13D/G 3 filers
Other insiders at Exagen Inc
All Exagen Inc insider activity
GET /v1/forms/4/0001274737-26-000058 API docs
View Original SEC Filing